Reversion from HBeAg negative to HBeAg positive phenotype after interferon therapy for chronic hepatitis B.

被引：0
|
作者：
Kitis, G [1 ]
Ilias, A [1 ]
Kapetanos, D [1 ]
Kiriazis, G [1 ]
机构：
[1] G Papanikolaou Hosp, Salonika, Greece
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1761
引用
收藏
页码：601A / 601A
页数：1
相关论文
共 50 条
  • [31] Genotypic and phenotypic resistance to lamivudine in patients with HBeAg negative chronic hepatitis B.
    Hussain, MT
    Carmela, C
    Gramenzi, A
    Fiorino, S
    Margotti, M
    Talarico, S
    Bernardi, M
    Andreone, P
    Lok, AS
    HEPATOLOGY, 2001, 34 (04) : 325A - 325A
  • [32] DIFFERENCE OF SERUM CYTOKINES EXPRESSION BETWEEN HBeAg-POSITIVE AND HBeAg-NEGATIVE CHRONIC HEPATITIS B
    He, D.
    Guo, S.
    Li, M.
    Zeng, X.
    Huang, H.
    Tan, Z.
    Wang, Y.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S535 - S535
  • [33] PEGYLATED INTERFERON ALFA-2A THERAPY FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B IN TAIWAN
    Lai, Hsueh-Chou
    Peng, Cheng-Yuan
    Su, Wen-Pang
    Chuang, Po-Heng
    HEPATOLOGY, 2010, 52 (04) : 549A - 549A
  • [34] INTRAHEPATIC HBSAG REDUCTION AFTER PEGINTERFERON TREATMENT IN HBEAG NEGATIVE AND HBEAG POSITIVE CHRONIC HEPATITIS B IS ASSOCIATED WITH SERUM HBSAG DECLINE
    Arends, P.
    Rijckborst, V.
    Sonneveld, M.
    Hansen, B.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S196 - S196
  • [35] Pegylated interferon alfa-2a therapy for HBeAg-negative chronic hepatitis B in Taiwan
    Lai, H. C.
    Peng, C. Y.
    Su, W. P.
    Chuang, P. H.
    Kao, J. T.
    Chou, J. W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A175 - A175
  • [36] Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection
    Hakan Senturk
    Birol Baysal
    Veysel Tahan
    Hasan Zerdali
    Resat Ozaras
    Fehmi Tabak
    Ali Mert
    Billur Canbakan
    Omur Tabak
    Gulsen Ozbay
    Digestive Diseases and Sciences, 2011, 56 : 208 - 212
  • [37] Long-Term Effect of Interferon Therapy in Patients with HBeAg Positive Chronic Hepatitis B Infection
    Senturk, Hakan
    Baysal, Birol
    Tahan, Veysel
    Zerdali, Hasan
    Ozaras, Resat
    Tabak, Fehmi
    Mert, Ali
    Canbakan, Billur
    Tabak, Omur
    Ozbay, Gulsen
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (01) : 208 - 212
  • [38] Response-guided peginterferon therapy for hbeag-positive and hbeag-negative chronic hepatitis b using hepatitis b surface antigen levels: A review
    Sonneveld M.J.
    Brouwer W.P.
    Janssen H.L.A.
    Current Hepatology Reports, 2014, 13 (3) : 250 - 255
  • [39] Analysis of clinical and virologic features in Hepatitis B e Antigen (HbeAg)-negative and HbeAg-positive Egyptian chronic hepatitis B patients
    Fouad, Rabab
    Musa, Sherief
    Sabry, Dina
    Salama, Ahmad
    Alem, Shereen Abdel
    Atef, Mira
    Zayed, Naglaa
    AFRICAN HEALTH SCIENCES, 2020, 20 (02) : 649 - 655
  • [40] A linear correlation exists between hepatitis B (HBV) DNA levels and fibrosis stage in HBeAg negative but not HBeAg positive chronic hepatitis B
    Croagh, C. M.
    Bell, S. J.
    Kong, Y.
    Chen, R.
    Shaw, G.
    Demediuk, B.
    Thompson, A. J. V.
    Locarnini, S.
    Desmond, P. V.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A283 - A283
12345